August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Sebastian Szmit: Phase 2 Trial with Dapagliflozin in Patients with Newly Diagnosed MM Undergoing Auto-HSCT
Jul 2, 2025, 08:14

Sebastian Szmit: Phase 2 Trial with Dapagliflozin in Patients with Newly Diagnosed MM Undergoing Auto-HSCT

Sebastian Szmit, Chair of the Council of Cardio-Oncology Study Group on Thrombosis at the European Society of Cardiology, shared a post on LinkedIn:

“Great Achievement!
Agencja Badań Medycznych will support our study entitled
A Randomized, Double‐Blind, Phase 2 Trial Evaluating the Efficacy, Safety, and Tolerability of Primary Cardioprotection with Dapagliflozin in Patients with Newly Diagnosed Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation (HEART‐DAPA‐ MM)
Congratulations to the Leaders.”

More posts featuring Sebastian Szmit.